ENDPOINTS

Vaxcyte aims to raise $1B after sharing pneumococcal vaccine data; More layoffs at Genentech

10 months ago

News Briefing

Denali details accelerated approval plans; Jazz's $850M private offering

10 months ago

News Briefing

J&J heads to FDA for Vyvgart competitor; Tokyo conglomerate launches venture fund

10 months ago

News Briefing

SpringWorks gets priority review; Botox competitor data; Hyundai's Covid treatment; Arcus takes a loan

10 months ago

News Briefing

Redalpine closes $200M fund; A base editing pact in China; Merck starts another Phase 3 for Imago drug

10 months ago

News Briefing

Mpox vaccine collab; $11M oncology seed; Gates backs RSV vaccine; Kyowa Kirin slims portfolio

10 months ago

News Briefing

Vandria raises another $10M; Nykode ends Phase 2 trial in cervical cancer

10 months ago

News Briefing

Kymera seeks to raise $225M; Adcendo, Multitude's new ADC deal

10 months ago

News Briefing

Avidity’s upsized $345M offering; Janus Henderson’s new $150M biotech fund

10 months ago

News Briefing

AN2’s poison pill; Pfizer shares promising mid-stage data for flu shot

10 months ago

News Briefing

Lyra pauses work on sinusitis drug; Pathos AI licenses a new asset

10 months ago

News Briefing

Kyverna shares safety data for CAR-T; Evotec gets $75M milestone

11 months ago

News Briefing

Tenax raises $100M; Sanofi buys into MeiraGTx

11 months ago

News Briefing

A CAR-T deal in China; Zevra’s $60M offering

11 months ago

News Briefing

Stoke Therapeutics’ partial hold lifted; Recursion gets $30M from Roche

11 months ago

News Briefing

Blueprint ups Ayvakit guidance; Aurinia to advance autoimmune disease asset

11 months ago

News Briefing

Ideaya and Biocytogen ink $400M+ deal; Daiichi spends more on superstar ADCs

11 months ago

News Briefing

Collegium pays $525M to buy ADHD company; FDA delays Syndax decision

11 months ago

News Briefing

Galderma deprioritizes study for IL-31 drug; UCB stops work in rare encephalitis

11 months ago

News Briefing

Telix's $397M convertible bond offering; Scynexis records a $10M milestone

11 months ago

News Briefing

Grünenthal inks a deal with Valinor; Valneva gets $41M from CEPI

11 months ago

News Briefing

Rona Therapeutics raises $35M; Actuate now plans for $22M IPO

11 months ago

News Briefing

Boehringer plans to again increase R&D spending; Valneva, Pfizer to advance Lyme vaccine candidate

11 months ago

News Briefing

SK to pay up to $571M in new radiopharma deal; Aslan lets go of all employees

11 months ago

News Briefing

about the author

author articles

Vaxcyte aims to raise $1B after sharing pneumococcal vaccine data; More layoffs at Genentech

Denali details accelerated approval plans; Jazz's $850M private offering

J&J heads to FDA for Vyvgart competitor; Tokyo conglomerate launches venture fund

SpringWorks gets priority review; Botox competitor data; Hyundai's Covid treatment; Arcus takes a loan

Redalpine closes $200M fund; A base editing pact in China; Merck starts another Phase 3 for Imago drug

Mpox vaccine collab; $11M oncology seed; Gates backs RSV vaccine; Kyowa Kirin slims portfolio

Vandria raises another $10M; Nykode ends Phase 2 trial in cervical cancer

Kymera seeks to raise $225M; Adcendo, Multitude's new ADC deal

Avidity’s upsized $345M offering; Janus Henderson’s new $150M biotech fund

AN2’s poison pill; Pfizer shares promising mid-stage data for flu shot

Lyra pauses work on sinusitis drug; Pathos AI licenses a new asset

Kyverna shares safety data for CAR-T; Evotec gets $75M milestone

Tenax raises $100M; Sanofi buys into MeiraGTx

A CAR-T deal in China; Zevra’s $60M offering

Stoke Therapeutics’ partial hold lifted; Recursion gets $30M from Roche

Blueprint ups Ayvakit guidance; Aurinia to advance autoimmune disease asset

Ideaya and Biocytogen ink $400M+ deal; Daiichi spends more on superstar ADCs

Collegium pays $525M to buy ADHD company; FDA delays Syndax decision

Galderma deprioritizes study for IL-31 drug; UCB stops work in rare encephalitis

Telix's $397M convertible bond offering; Scynexis records a $10M milestone

Grünenthal inks a deal with Valinor; Valneva gets $41M from CEPI

Rona Therapeutics raises $35M; Actuate now plans for $22M IPO

Boehringer plans to again increase R&D spending; Valneva, Pfizer to advance Lyme vaccine candidate

SK to pay up to $571M in new radiopharma deal; Aslan lets go of all employees